Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement

Details for Australian Patent Application No. 2007225044 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Rother, Russell P.; Bell, Leonard

Agent Shelston IP

Pub. Number AU-A-2007225044

PCT Pub. Number WO2007/106585

Priority 60/783,070 15.03.06 US

Filing date 15 March 2007

Wipo publication date 20 September 2007

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/106585 Priority application(s): WO2007/106585

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007225048-Method for percutaneously administering reduced pressure treatment using balloon dissection

2007225040-Preparation and storage of stable, antimicrobially active materials